Core Points - The company reported a revenue of 9.523 billion yuan for 2024, representing a year-on-year growth of 37.65%, and a net profit of 1.465 billion yuan, which is an increase of 282.63% compared to the previous year [2][7] - The company achieved a capacity utilization rate of 100% and focused on optimizing market layout to gain more market share, leading to significant performance growth [2][3] - The company is facing an 80% tariff on medical-grade nitrile gloves, a 55% tariff on industrial-grade nitrile gloves, and a 30% tariff on PVC gloves in the U.S. market, which accounts for approximately 30%-35% of its overseas revenue [4][7] Performance Disclosure - For 2024, the company reported a revenue of 9.523 billion yuan, a 37.65% increase year-on-year, and a net profit of 1.465 billion yuan, reflecting a 282.63% growth compared to the previous year [2][7] - The company maintained a capacity utilization rate of 100%, indicating strong operational efficiency [2] Institutional Research - During the performance briefing on May 19, the company attributed its 2024 growth to improved supply-demand dynamics in the disposable glove industry and increased sales prices compared to 2023 [3] - The company is leveraging its production, capital, and sales channel advantages to capture a larger market share [3] Company Announcements - The company has repurchased 2,523,900 shares, accounting for 0.3906% of its total share capital, with a total transaction amount of approximately 53.52 million yuan [5] - The company plans to distribute a total cash dividend of approximately 269.61 million yuan for 2024, which represents 18.40% of the net profit attributable to shareholders [6] - The company is adjusting its 2022 restricted stock incentive plan's performance assessment indicators due to geopolitical complexities and trade friction risks, which will be submitted for shareholder approval [8]

Group 1: Financial Performance - In 2024, the company's operating revenue reached CNY 95.23 billion, a year-on-year increase of 282.63% [2] - The net profit attributable to shareholders was CNY 14.65 billion, with a sales price increase of 37.65% compared to the previous year [2][3] - The company's capacity utilization rate was 100% during the reporting period, indicating strong operational efficiency [3] Group 2: Market Dynamics - The U.S. imposes tariffs of 80% on medical-grade nitrile gloves, 55% on industrial-grade nitrile gloves, and 30% on PVC gloves [3] - The U.S. market accounted for approximately 30%-35% of overseas revenue, with European markets growing at a similar pace [3] - The company has been diversifying its market strategy, reducing reliance on the U.S. market since the trade tensions began in 2018 [3] Group 3: Share Buyback and Dividends - As of April 30, 2025, the company repurchased 2,523,900 shares, representing 0.3906% of total equity, with a total expenditure of CNY 53,518,589.28 [4] - The proposed cash dividend for 2024 is approximately CNY 269.61 million, which is 18.40% of the net profit attributable to shareholders [5] - The company plans to maintain sufficient funds to mitigate geopolitical risks and support the establishment of overseas production bases [5]

Group 1: Share Buyback and Dividend Distribution - The company has repurchased a total of 21,030,307 shares as of April 30, 2025, with a total transaction amount of RMB 467,953,973.43 (excluding transaction fees) [2][4] - In 2024, the company distributed cash dividends amounting to RMB 32,068,908.15 (including tax) [4] - The proposed total cash dividend for 2024 is approximately RMB 63,916,500 (including tax), which represents 18.40% of the net profit attributable to shareholders [5] Group 2: Market Management and Strategy - The company is actively enhancing market competitiveness by expanding both domestic and international markets, optimizing business layout, and increasing market share [3] - The company has implemented a market diversification strategy, reducing the proportion of revenue from the U.S. market, which currently accounts for approximately 30%-35% of overseas revenue [3] - The current tariffs for medical-grade nitrile gloves exported to the U.S. are 80%, while industrial-grade nitrile gloves are subject to a 55% tariff, and PVC gloves face a 30% tariff [3] Group 3: Share Buyback Progress - As of April 30, 2025, the company has repurchased 2,523,900 shares, representing 0.3906% of the total share capital of 646,204,669 shares [5] - The highest and lowest transaction prices for the repurchased shares were RMB 23.89 and RMB 20.06 per share, respectively, with a total transaction amount of RMB 53,518,589.28 (excluding transaction fees) [5]